Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
9 Months Ended 12 Months Ended
Mar. 31, 2017
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]      
Contract research and government grants   $ 469,532 $ 254,834
Revenue   16,964
Total revenue $ 468,032 486,496 254,834
Operating expenses      
Research and development 2,590,698 4,425,778 1,758,701
General and administrative expenses 4,533,652 6,019,285 2,935,299
Total operating expenses 7,124,350 10,445,063 4,694,000
Loss from operations (6,656,318) (9,958,567) (4,439,166)
Other income (expense)      
Other income   500
Interest income 970 1,936 1,339
Bargain purchase   1,725,881
Change in fair value of derivative liabilities (877,490) (877,490) (968,840)
Total other income (expense) (876,520) 850,327 (967,001)
Net loss $ (7,532,838) $ (9,108,240) $ (5,406,167)
Net loss per common share - basic and diluted (in dollars per share) $ 0 $ (0.54) $ (0.40)
Weighted average common shares outstanding - basic and diluted (in shares) 16,419,225 16,990,536 13,349,482